$USNA
USANA HEALTH SCIENCES INC

2024 Q3 Form 10-Q Financial Statement

#000089626424000208 Filed on August 06, 2024

View on sec.gov

Income Statement

Concept 2024 Q3 2024 Q2
Revenue $200.2M $212.9M
YoY Change -15.94% -14.29%
Cost Of Revenue $39.26M $40.33M
YoY Change -9.39% -16.87%
Gross Profit $161.0M $172.5M
YoY Change -17.4% -13.66%
Gross Profit Margin 80.39% 81.05%
Selling, General & Admin $145.4M $154.7M
YoY Change -14.73% 131.14%
% of Gross Profit 90.31% 89.66%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $3.569M $3.813M
YoY Change 10.84% 15.58%
% of Gross Profit 2.22% 2.21%
Operating Expenses $145.4M $154.7M
YoY Change -14.73% -10.58%
Operating Profit $15.60M $17.84M
YoY Change -36.06% -33.54%
Interest Expense $3.093M $2.712M
YoY Change 7093.02% 8648.39%
% of Operating Profit 19.83% 15.2%
Other Income/Expense, Net -$86.00K -$349.0K
YoY Change -103.57% -121.07%
Pretax Income $18.61M $20.20M
YoY Change -30.59% -29.11%
Income Tax $8.001M $9.771M
% Of Pretax Income 43.0% 48.36%
Net Earnings $10.61M $10.43M
YoY Change -38.66% -43.25%
Net Earnings / Revenue 5.3% 4.9%
Basic Earnings Per Share $0.56 $0.55
Diluted Earnings Per Share $0.56 $0.54
COMMON SHARES
Basic Shares Outstanding 19.05M shares 19.05M shares
Diluted Shares Outstanding 19.08M shares 19.16M shares

Balance Sheet

Concept 2024 Q3 2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $364.9M $332.4M
YoY Change 21.56% 12.51%
Cash & Equivalents $364.9M $332.4M
Short-Term Investments
Other Short-Term Assets $22.32M $24.83M
YoY Change -12.48% -30.91%
Inventory $63.98M $61.83M
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets $451.2M $419.1M
YoY Change 16.39% 5.86%
LONG-TERM ASSETS
Property, Plant & Equipment $98.03M $97.69M
YoY Change 2.4% 0.92%
Goodwill $17.20M $16.84M
YoY Change 2.0% -3.3%
Intangibles $29.24M $28.64M
YoY Change -2.53% -10.43%
Long-Term Investments $20.00M $20.00M
YoY Change 0.0%
Other Assets $75.65M $69.18M
YoY Change 4.43% 24.41%
Total Long-Term Assets $220.1M $212.3M
YoY Change 2.36% 1.28%
TOTAL ASSETS
Total Short-Term Assets $451.2M $419.1M
Total Long-Term Assets $220.1M $212.3M
Total Assets $671.3M $631.4M
YoY Change 11.39% 4.27%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $7.041M $6.648M
YoY Change -24.07% -36.75%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00
YoY Change
Long-Term Debt Due $0.00 $0.00
YoY Change
Total Short-Term Liabilities $114.8M $103.9M
YoY Change 0.83% -20.22%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00
YoY Change
Other Long-Term Liabilities $18.72M $10.66M
YoY Change 22.96% -25.87%
Total Long-Term Liabilities $18.72M $10.66M
YoY Change 22.96% -25.87%
TOTAL LIABILITIES
Total Short-Term Liabilities $114.8M $103.9M
Total Long-Term Liabilities $18.72M $10.66M
Total Liabilities $138.2M $119.2M
YoY Change 3.26% -17.56%
SHAREHOLDERS EQUITY
Retained Earnings $474.5M $463.9M
YoY Change 11.04% 13.14%
Common Stock $72.30M $68.83M
YoY Change 20.52% 22.11%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $533.1M $512.2M
YoY Change
Total Liabilities & Shareholders Equity $671.3M $631.4M
YoY Change 11.39% 4.27%

Cashflow Statement

Concept 2024 Q3 2024 Q2
OPERATING ACTIVITIES
Net Income $10.61M $10.43M
YoY Change -38.66% -43.25%
Depreciation, Depletion And Amortization $3.569M $3.813M
YoY Change 10.84% 15.58%
Cash From Operating Activities $29.53M $7.990M
YoY Change 209.22% -37.74%
INVESTING ACTIVITIES
Capital Expenditures $2.399M $2.671M
YoY Change -33.53% 26.77%
Acquisitions
YoY Change
Other Investing Activities $61.00K $1.125M
YoY Change -98.39% -188.51%
Cash From Investing Activities -$2.338M -$1.546M
YoY Change -1406.15% -54.23%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -78.00K -1.353M
YoY Change 41.82% -57.71%
NET CHANGE
Cash From Operating Activities 29.53M 7.990M
Cash From Investing Activities -2.338M -1.546M
Cash From Financing Activities -78.00K -1.353M
Net Change In Cash 27.12M 5.091M
YoY Change 180.29% -27.75%
FREE CASH FLOW
Cash From Operating Activities $29.53M $7.990M
Capital Expenditures $2.399M $2.671M
Free Cash Flow $27.14M $5.319M
YoY Change 356.66% -50.41%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
333246000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
291320000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
13910000 usd
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
0 shares
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
486562000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
486562000 usd
CY2023Q2 us-gaap Stockholders Equity
StockholdersEquity
455354000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
26572000 usd
us-gaap Income Taxes Paid
IncomeTaxesPaid
28817000 usd
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
5000 usd
us-gaap Proceeds From Income Tax Refunds
ProceedsFromIncomeTaxRefunds
680000 usd
usna Right Of Use Assets Obtained In Exchange For Lease Obligations
RightOfUseAssetsObtainedInExchangeForLeaseObligations
4688000 usd
CY2023Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
19130000 shares
CY2023Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
19130000 shares
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
2916000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
468824000 usd
us-gaap Net Income Loss
NetIncomeLoss
26969000 usd
us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-6813000 usd
us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
7403000 usd
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
9483000 usd
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
3070000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
512208000 usd
CY2023Q3 us-gaap Net Income Loss
NetIncomeLoss
17292000 usd
CY2023Q3 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-7441000 usd
CY2023Q3 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3674000 usd
CY2023Q3 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2023Q3 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
55000 usd
CY2023Q3 us-gaap Stockholders Equity
StockholdersEquity
468824000 usd
CY2024Q1 us-gaap Stockholders Equity
StockholdersEquity
499988000 usd
CY2024Q2 us-gaap Net Income Loss
NetIncomeLoss
10432000 usd
CY2024Q2 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-1915000 usd
CY2024Q2 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3734000 usd
CY2024Q2 us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
0 usd
CY2024Q2 us-gaap Adjustments Related To Tax Withholding For Share Based Compensation
AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation
31000 usd
CY2024Q2 us-gaap Stockholders Equity
StockholdersEquity
512208000 usd
us-gaap Net Income Loss
NetIncomeLoss
26969000 usd
us-gaap Net Income Loss
NetIncomeLoss
35675000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6971000 usd
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
6519000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3815000 usd
us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
3846000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-17000 usd
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
12000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7403000 usd
us-gaap Share Based Compensation
ShareBasedCompensation
7282000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-4918000 usd
us-gaap Deferred Income Taxes And Tax Credits
DeferredIncomeTaxesAndTaxCredits
-5026000 usd
us-gaap Inventory Write Down
InventoryWriteDown
1512000 usd
us-gaap Inventory Write Down
InventoryWriteDown
2684000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
4486000 usd
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
550000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-225000 usd
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-1986000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-3310000 usd
us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1171000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-8525000 usd
us-gaap Increase Decrease In Other Operating Liabilities
IncreaseDecreaseInOtherOperatingLiabilities
-28849000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
25673000 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
22384000 usd
us-gaap Proceeds From Hedge Investing Activities
ProceedsFromHedgeInvestingActivities
1125000 usd
us-gaap Proceeds From Hedge Investing Activities
ProceedsFromHedgeInvestingActivities
3775000 usd
us-gaap Payments For Hedge Investing Activities
PaymentsForHedgeInvestingActivities
870000 usd
us-gaap Payments For Hedge Investing Activities
PaymentsForHedgeInvestingActivities
1271000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3000 usd
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
13000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5872000 usd
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
5716000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-5614000 usd
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-3199000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
9444000 usd
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
0 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
691000 usd
us-gaap Proceeds From Lines Of Credit
ProceedsFromLinesOfCredit
750000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
1476000 usd
us-gaap Repayments Of Lines Of Credit
RepaymentsOfLinesOfCredit
750000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
3070000 usd
us-gaap Payments Related To Tax Withholding For Share Based Compensation
PaymentsRelatedToTaxWithholdingForShareBasedCompensation
2916000 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
0 usd
us-gaap Payment For Contingent Consideration Liability Financing Activities
PaymentForContingentConsiderationLiabilityFinancingActivities
338000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-13299000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3254000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4831000 usd
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-4310000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1929000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
11621000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
335175000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
302941000 usd
CY2024Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
332423000 usd
CY2023Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
300183000 usd
CY2024Q2 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2752000 usd
CY2023Q3 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
2758000 usd
CY2024Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
335175000 usd
CY2023Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
302941000 usd
us-gaap Interest Paid Net
InterestPaidNet
72000 usd
us-gaap Interest Paid Net
InterestPaidNet
3000 usd
usna Right Of Use Assets Obtained In Exchange For Lease Obligations
RightOfUseAssetsObtainedInExchangeForLeaseObligations
613000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
57000 usd
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
132000 usd
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
39000 usd
us-gaap Excise And Sales Taxes
ExciseAndSalesTaxes
0 usd
usna Number Of Geographic Regions
NumberOfGeographicRegions
2 region
usna Number Of Sub Geographical Regions
NumberOfSubGeographicalRegions
3 region
us-gaap Use Of Estimates
UseOfEstimates
The preparation of condensed consolidated financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from these estimates. In the opinion of the Company’s management, the accompanying interim condensed consolidated financial information contains all adjustments, consisting only of normal recurring adjustments that are necessary to state fairly the Company’s financial position as of June 29, 2024, and results of operations and cash flows for the three and six months ended June 29, 2024 and July 1, 2023.
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div style="margin-top:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications have been made to prior period amounts to conform to current period presentation. These reclassifications relate to the disaggregation of inventory write-downs from changes in inventories within operating activities of the condensed consolidated statements of cash flows.</span></div>
CY2024Q2 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
21901000 usd
CY2023Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
19848000 usd
CY2024Q2 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4306000 usd
CY2023Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
4707000 usd
CY2024Q2 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
35625000 usd
CY2023Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
36899000 usd
CY2024Q2 us-gaap Inventory Net
InventoryNet
61832000 usd
CY2023Q4 us-gaap Inventory Net
InventoryNet
61454000 usd
CY2024Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
3075000 usd
CY2023Q4 us-gaap Inventory Noncurrent
InventoryNoncurrent
3128000 usd
CY2024Q2 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
CY2023Q3 us-gaap Equity Securities Without Readily Determinable Fair Value Impairment Loss Annual Amount
EquitySecuritiesWithoutReadilyDeterminableFairValueImpairmentLossAnnualAmount
0 usd
CY2024Q2 us-gaap Other Income
OtherIncome
644000 usd
CY2023Q3 us-gaap Other Income
OtherIncome
755000 usd
us-gaap Other Income
OtherIncome
1362000 usd
us-gaap Other Income
OtherIncome
1481000 usd
CY2023Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
13910000 usd
CY2022Q4 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
20875000 usd
usna Increase Due To Deferral Of Revenue At End Of Period
IncreaseDueToDeferralOfRevenueAtEndOfPeriod
9802000 usd
CY2023 usna Increase Due To Deferral Of Revenue At End Of Period
IncreaseDueToDeferralOfRevenueAtEndOfPeriod
13910000 usd
us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
11853000 usd
CY2023 us-gaap Contract With Customer Liability Revenue Recognized
ContractWithCustomerLiabilityRevenueRecognized
20875000 usd
CY2024Q2 us-gaap Contract With Customer Liability
ContractWithCustomerLiability
11859000 usd
CY2024Q2 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
0 usd
CY2023Q4 us-gaap Lines Of Credit Current
LinesOfCreditCurrent
786000 usd
CY2024Q2 us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
255000 usd
us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
255000 usd
CY2023Q3 us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
2504000 usd
us-gaap Derivative Gain On Derivative
DerivativeGainOnDerivative
2504000 usd
CY2024Q2 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
10432000 usd
CY2023Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
17292000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
26969000 usd
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
35675000 usd
CY2024Q2 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19073000 shares
CY2023Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19321000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19123000 shares
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
19302000 shares
CY2024Q2 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
86000 shares
CY2023Q3 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
106000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
107000 shares
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
75000 shares
CY2024Q2 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19159000 shares
CY2023Q3 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19427000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19230000 shares
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
19377000 shares
CY2024Q2 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.55
CY2023Q3 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.89
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.41
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.85
CY2024Q2 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.54
CY2023Q3 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.89
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.40
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.84
CY2024Q2 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
696000 shares
CY2023Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
354000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
541000 shares
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
325000 shares
CY2024Q2 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
CY2023Q3 us-gaap Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
0 shares
us-gaap Stock Repurchased And Retired During Period Shares
StockRepurchasedAndRetiredDuringPeriodShares
194000 shares
us-gaap Stock Repurchased And Retired During Period Value
StockRepurchasedAndRetiredDuringPeriodValue
9483000 usd
CY2024Q2 usna Stock Repurchased Excise Tax Payable
StockRepurchasedExciseTaxPayable
39000 usd
CY2024Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
61703000 usd
us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1 segment
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
212869000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
238202000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
440669000 usd
CY2024Q2 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
212869000 usd
CY2023Q3 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
238202000 usd
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
440669000 usd
CY2024Q2 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q2 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q2 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
0000896264-24-000208-index-headers.html Edgar Link pending
0000896264-24-000208-index.html Edgar Link pending
0000896264-24-000208.txt Edgar Link pending
0000896264-24-000208-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
usna-20240629.htm Edgar Link pending
usna-20240629.xsd Edgar Link pending
usna-20240629xex311.htm Edgar Link pending
usna-20240629xex312.htm Edgar Link pending
usna-20240629xex321.htm Edgar Link pending
usna-20240629xex322.htm Edgar Link pending
usna-20240629_cal.xml Edgar Link unprocessable
usna-20240629_def.xml Edgar Link unprocessable
usna-20240629_lab.xml Edgar Link unprocessable
usna-20240629_pre.xml Edgar Link unprocessable
usna-20240629_htm.xml Edgar Link completed